It was reported that CD163+ tumor-associated macrophages could inhibit T-cell proliferation and activation by secreting CCL22, IL-10, and TGF-β and recruiting regulatory T cells (Tregs) to tumor tissues (22, 23). Here, CCL22 is linked to neoplasm.